Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo.
Recruiting
- Conditions
- Ardox-X® Technology, novo plaque
- Registration Number
- NL-OMON25700
- Lead Sponsor
- ACTA Dental Research B.V.
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1. ≥ 18 years;
2. Systemically healthy;
Exclusion Criteria
1. The use of antibiotics during the last 6 months;
2. Dutch Periodontal Screening Index (DPSI) ≥3+;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Modified Quigley & Hein index.
- Secondary Outcome Measures
Name Time Method 1. The Bleeding on marginal probing (BOMP) index;<br /><br>2. Results from the VAS questionnaire to evaluate the subject’s attitude towards the used products;<br /><br>3. Microbiological analysis to monitor shifts in the composition of the microbiota;<br /><br>4. QLF.